SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Norris Medicines informs about outcome of board meeting

15 Sep 2022 Evaluate
Norris Medicines has informed that the Board of Directors of the Company at its meeting held on Thursday, the 15th September, 2022 has granted its approval to make an application to Registrar of Companies for seeking extension of time to hold the Annual General Meeting for the financial year ended 31st March, 2022 by three months due to administrative reasons faced by the Company.

The above information is a part of company’s filings submitted to BSE.

Norris Medicines Share Price

14.97 0.22 (1.49%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×